Cadrenal Therapeutics announces annual shareholder meeting
Reuters2026/08/03 21:10- Cadrenal Therapeutics will hold its annual shareholder meeting virtually on Sept. 24, 2026.
- Shareholders will vote on the election of a Class I director, with Quang X. Pham nominated for a three-year term.
- Ballot includes a plan to raise the 2022 equity incentive plan share pool by 323,542 shares to 1,000,000 shares.
- Investors will also vote on issuing up to 960,000 shares upon exercise of Series C-1 warrants from a July 1, 2026 private placement.
- Meeting may be adjourned to allow additional solicitation tied to the equity plan amendment or warrant exercise proposals.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Delta Electronics (Thailand)'s Recent Selloff Presents Accumulation Opportunity -- Market Talk
The data center construction boom may increase inflationary pressure, and the Reserve Bank of Australia may be forced to maintain high interest rates.
The data center construction boom in Australia may lead to demand exceeding the supply capacity of the economy, which could push up inflation and force the Reserve Bank of Australia to maintain higher interest rates.
Reliance step-down unit Roptonal dissolves in Cyprus with effect Aug. 18, 2026
Crypto prices
More
